Albany C et al (2021) Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724). Support Care Cancer 29(2):833–840
Alotaibi M et al (2022) Alleviation of cisplatin-induced neuropathic pain, neuronal apoptosis, and systemic inflammation in mice by rapamycin. Front Aging Neurosci 14:891593
Article PubMed PubMed Central CAS Google Scholar
An Q et al (2021) Calcitonin gene-related peptide regulates spinal microglial activation through the histone H3 lysine 27 trimethylation via enhancer of zeste homolog-2 in rats with neuropathic pain. J Neuroinflammation 18(1):117
Article PubMed PubMed Central CAS Google Scholar
Argyriou AA et al (2012) Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol 82(1):51–77
Banach M, Juranek JK, Zygulska AL (2017) Chemotherapy-induced neuropathies-a growing problem for patients and health care providers. Brain Behav 7(1):e00558
Benschop RJ et al (2014) Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain. Osteoarthr Cartil 22(4):578–585
Boulikas T, Vougiouka M (2003) Cisplatin and platinum drugs at the molecular level (review). Oncol Rep 10(6):1663–1682
Canta A, Pozzi E, Carozzi VA (2015) Mitochondrial dysfunction in chemotherapy-induced peripheral neuropathy (CIPN). Toxics 3(2):198–223
Article PubMed PubMed Central CAS Google Scholar
Cao A et al (2023) Effect of exercise on chemotherapy-induced peripheral neuropathy among patients treated for ovarian cancer: a secondary analysis of a randomized clinical trial. JAMA Netw Open 6(8):e2326463
Article PubMed PubMed Central Google Scholar
Cavaletti G, Marmiroli P (2015) Chemotherapy-induced peripheral neurotoxicity. Curr Opin Neurol 28(5):500–507
Article PubMed CAS Google Scholar
Chaplan SR et al (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53(1):55–63
Article PubMed CAS Google Scholar
Colvin LA (2019) Chemotherapy-induced peripheral neuropathy: where are we now? Pain 160(Suppl 1):S1–S10
Article PubMed PubMed Central CAS Google Scholar
De Logu F et al (2022) Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice. Nat Commun 13(1):646
Article PubMed PubMed Central Google Scholar
Domingo IK, Latif A, Bhavsar AP (2022) Pro-inflammatory signalling PRRopels cisplatin-induced toxicity. Int J Mol Sci 23(13)
Flatters SJL, Dougherty PM, Colvin LA (2017) Clinical and preclinical perspectives on chemotherapy-induced peripheral neuropathy (CIPN): a narrative review. Br J Anaesth 119(4):737–749
Article PubMed CAS Google Scholar
Fumagalli G et al (2020) Neuroinflammatory process involved in different preclinical models of chemotherapy-induced peripheral neuropathy. Front Immunol 11:626687
Article PubMed CAS Google Scholar
Gregg RW et al (1992) Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. J Clin Oncol 10(5):795–803
Article PubMed CAS Google Scholar
Hansen RR et al (2016) Role of extracellular calcitonin gene-related peptide in spinal cord mechanisms of cancer-induced bone pain. Pain 157(3):666–676
Article PubMed CAS Google Scholar
Huang X et al (2021) Downregulation of metallothionein-2 contributes to oxaliplatin-induced neuropathic pain. J Neuroinflammation 18(1):91
Article PubMed PubMed Central CAS Google Scholar
Iyengar S, Ossipov MH, Johnson KW (2017) The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine. Pain 158(4):543–559
Article PubMed PubMed Central CAS Google Scholar
Janes K et al (2015) Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy. Brain Behav Immun 44:91–99
Article PubMed CAS Google Scholar
Jordan B et al (2020) Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol 31(10):1306–1319
Article PubMed CAS Google Scholar
Kerckhove N et al (2017) Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review. Front Pharmacol 8:86
Article PubMed PubMed Central Google Scholar
Krukowski K et al (2017) HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy. Pain 158(6):1126–1137
Article PubMed PubMed Central CAS Google Scholar
Labastida-Ramírez A et al (2023) Mode and site of action of therapies targeting CGRP signaling. J Headache Pain 24(1):125
Article PubMed PubMed Central Google Scholar
Leo M et al (2021a) Cisplatin-induced activation and functional modulation of satellite glial cells lead to cytokine-mediated modulation of sensory neuron excitability. Exp Neurol 341:113695
Article PubMed CAS Google Scholar
Leo M et al (2021b) Modulation of glutamate transporter EAAT1 and inward-rectifier potassium channel K(ir4.1) expression in cultured spinal cord astrocytes by platinum-based chemotherapeutics. Int J Mol Sci 22(12)
Li Y et al (2015) MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy. Brain Behav Immun 49:255–266
Article PubMed PubMed Central CAS Google Scholar
Li Y et al (2018) DRG voltage-gated sodium channel 1.7 is upregulated in paclitaxel-induced neuropathy in rats and in humans with neuropathic pain. J Neurosci 38(5):1124–1136
Article PubMed PubMed Central CAS Google Scholar
Liddelow SA et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638):481–487
Article PubMed PubMed Central CAS Google Scholar
Ma X et al (2022) Spinal neuronal GRK2 contributes to preventive effect by electroacupuncture on cisplatin-induced peripheral neuropathy in mice. Anesth Analg 134(1):204–215
Article PubMed CAS Google Scholar
Makker PG et al (2017) Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy. PLoS ONE 12(1):e0170814
Article PubMed PubMed Central Google Scholar
McDonald ES et al (2005) Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity. Neurobiol Dis 18(2):305–313
Article PubMed CAS Google Scholar
Mei C et al (2023) Trimethoxyflavanone relieves paclitaxel-induced neuropathic pain via inhibiting expression and activation of P2X7 and production of CGRP in mice. Neuropharmacology 236:109584
Article PubMed CAS Google Scholar
Navia-Pelaez JM et al (2021) Normalization of cholesterol metabolism in spinal microglia alleviates neuropathic pain. J Exp Med 218(7)
Park JH et al (2015) Oxaliplatin-induced peripheral neuropathy via TRPA1 stimulation in mice dorsal root ganglion is correlated with aluminum accumulation. PLoS ONE 10(4):e0124875
Article PubMed PubMed Central Google Scholar
Robinson CR, Zhang H, Dougherty PM (2014) Astrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the rat. Neuroscience 274:308–317
Article PubMed CAS Google Scholar
Russo AF (2015) Calcitonin gene-related peptide (CGRP): a new target for migraine. Annu Rev Pharmacol Toxicol 55:533–552
Article PubMed CAS Google Scholar
Schmitt LI et al (2020) Activation and functional modulation of satellite glial cells by oxaliplatin lead to hyperexcitability of sensory neurons in vitro. Mol Cell Neurosci 105:103499
Article PubMed CAS Google Scholar
Seretny M et al (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461–2470
留言 (0)